Skip to main content
. 2020 Jul 3;34(4):1715–1727. doi: 10.21873/invivo.11965

Figure 3. Similarities and differences between the molecular classification of triple-negative breast cancer. BL: Basal-like. BL1: Basal-like 1. BL2: Basal-like 2. BLIS: Basal-like immune suppressed. BLIA: Basal-like immune-activated. IM: Immunomodulatory. M: Mesenchymal. MSL: Mesenchymal stem-like. LAR: Luminal androgen receptor. UNS: Unstable. LA: Luminal/apocrine. HER2-e: HER2-enriched. AR+: Androgen receptor positive. QN: Quadruple-negative breast cancer. CLDN-l: Claudin-low. CLDN-h: Claudin-high.

Figure 3